254 related articles for article (PubMed ID: 34224813)
61.
N Ogbu P; U S Ezeanyika L; Ogugua VNE; M Ogbu I; Aloke C; N Ony G
Pak J Biol Sci; 2021 Jan; 24(1):151-157. PubMed ID: 33683042
[TBL] [Abstract][Full Text] [Related]
62. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
64. α-Spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model.
Lee MY; Shin IS; Kyoung H; Seo CS; Son JK; Shin HK
Mol Med Rep; 2014 Jun; 9(6):2362-6. PubMed ID: 24682042
[TBL] [Abstract][Full Text] [Related]
65. Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation.
Zhang B; Chen X; Gan Y; Li BS; Wang KN; He Y
Ann Transl Med; 2021 Aug; 9(15):1246. PubMed ID: 34532383
[TBL] [Abstract][Full Text] [Related]
66. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
[TBL] [Abstract][Full Text] [Related]
67. A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.
Manjunatha R; Pundarikaksha HP; Madhusudhana HR; Amarkumar J; Hanumantharaju BK
Indian J Pharmacol; 2016; 48(2):134-40. PubMed ID: 27127315
[TBL] [Abstract][Full Text] [Related]
68. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
69. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach.
Rasheed RA; Sadek AS; Khattab RT; Elkhamisy FAA; Abdelfattah HA; Elshaer MMA; Almutairi SM; Hussein DS; Embaby AS; Almoatasem MAM
PLoS One; 2023; 18(11):e0293682. PubMed ID: 37943844
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study.
Rosen RC; Roehrborn CG; Manyak MJ; Palacios-Moreno JM; Wilson TH; Lulic Z; Giuliano F
Int J Clin Pract; 2019 Sep; 73(9):1-9. PubMed ID: 30317693
[TBL] [Abstract][Full Text] [Related]
71. The Effects of
Kim NH; Jegal J; Kim YN; Heo JD; Rho JR; Yang MH; Jeong EJ
Nutrients; 2020 May; 12(6):. PubMed ID: 32481550
[TBL] [Abstract][Full Text] [Related]
72. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
[TBL] [Abstract][Full Text] [Related]
73. The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus.
Daryanto B; Naim HY; Budaya TN
Med Arch; 2023 Feb; 77(1):13-17. PubMed ID: 36919125
[TBL] [Abstract][Full Text] [Related]
74. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction.
Traish A; Haider KS; Doros G; Haider A
Horm Mol Biol Clin Investig; 2017 Jun; 30(3):. PubMed ID: 28632494
[TBL] [Abstract][Full Text] [Related]
75. [The effects of dutasteride on voiding and storage symptoms in men with benign prostatic hyperplasia].
Tsukamoto T; Shirai T; Sakamoto S; Akiyama A; Takeuchi H; Yajima M; Terao T; Endo Y
Hinyokika Kiyo; 2010 Dec; 56(12):677-82. PubMed ID: 21273805
[TBL] [Abstract][Full Text] [Related]
76. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.
Krishnamoorthi R; Ganapathy A A; Hari Priya VM; Kumaran A
J Ethnopharmacol; 2024 Aug; 330():118207. PubMed ID: 38636573
[TBL] [Abstract][Full Text] [Related]
77. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.
Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J
Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149
[TBL] [Abstract][Full Text] [Related]
78. Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.
Jung Y; Park J; Kim HL; Youn DH; Kang J; Lim S; Jeong MY; Sethi G; Park SJ; Ahn KS; Um JY
Oncotarget; 2017 Oct; 8(50):87194-87208. PubMed ID: 29152074
[TBL] [Abstract][Full Text] [Related]
79. The Effect of Long-Term Tamsulosin Monotherapy and Tamsulosin - Dutasteride Combination Therapy on PKC-α Enzyme Expression in Prostate Stromal Tissue.
Daryanto B; Purnomo AF; Patriawan YS; Purnomo BB
Med Arch; 2023; 77(6):446-450. PubMed ID: 38313112
[TBL] [Abstract][Full Text] [Related]
80. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.
Kuiper JG; Bezemer ID; Driessen MT; Vasylyev A; Roehrborn CG; Penning-van Beest FJ; Herings RM
BMC Urol; 2016 Aug; 16(1):53. PubMed ID: 27580700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
